Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (BHU), Varanasi 221005, Uttar Pradesh, India.
School of Biomedical Engineering, Indian Institute of Technology (BHU), Varanasi 221005, Uttar Pradesh, India.
Int J Biol Macromol. 2024 Nov;279(Pt 4):135532. doi: 10.1016/j.ijbiomac.2024.135532. Epub 2024 Sep 10.
The present work focuses on the fabrication of polyvinyl alcohol-chitosan-loaded oleanolic acid-nanofibers (PVA-CS-OLA-NFs) for bacterial infection. The prepared PVA-CS-OLA-NFs were characterized for contact angle, SEM, AFM, XRD, FTIR, and TGA. The solid-state characterization and in vitro performance evaluation of nanofibers reveal consistent interconnection and diameters ranging from 102 ± 9.5 to 386 ± 11.6 nm. The nanofibers have a flat surface topography and exhibit efficient drug entrapment. Moreover, the in vitro release profile of PVA-CS-OLA-NFs was found to be 51.82 ± 1.49 % at 24 h. Furthermore, the hemocompatibility study showed that the developed PVA-CS-OLA-NFs are non-hemolytic to human blood. The PVA-CS-OLA-NFs demonstrate remarkable antibacterial capabilities, as evidenced by their MBC and MIC values, which range from 128 and 32 μg/mL, against the strains of S. aureus. The in-vivo fluorescence optical imaging showed the sustained PVA-CS-OLA-NFs release at the wound site infected with S. aureus for a longer duration of time. Moreover, the PVA-CS-OLA-NFs showed superior wound healing performance against S. aureus infected wounds compared to the marketed formulation. Further, the laser Doppler imaging system improved oxygen saturation, blood supply, and wound healing by providing real-time blood flow and oxygen saturation information.
本工作专注于制备负载齐墩果酸的聚乙烯醇-壳聚糖纳米纤维(PVA-CS-OLA-NFs)用于细菌感染。所制备的 PVA-CS-OLA-NFs 进行了接触角、SEM、AFM、XRD、FTIR 和 TGA 等特性表征。纳米纤维的固态特征和体外性能评估表明,其具有一致的互联性和直径分布,范围为 102 ± 9.5 至 386 ± 11.6nm。纳米纤维具有平坦的表面形貌,表现出高效的药物包埋性能。此外,PVA-CS-OLA-NFs 的体外释放曲线在 24 小时时达到 51.82 ± 1.49%。此外,血液相容性研究表明,所开发的 PVA-CS-OLA-NFs 对人血无溶血作用。PVA-CS-OLA-NFs 表现出显著的抗菌能力,MBC 和 MIC 值范围分别为 128 和 32μg/mL,对金黄色葡萄球菌菌株有效。体内荧光光学成像显示,PVA-CS-OLA-NFs 在金黄色葡萄球菌感染的伤口部位持续释放,持续时间更长。此外,与市售制剂相比,PVA-CS-OLA-NFs 在金黄色葡萄球菌感染的伤口中表现出更好的伤口愈合性能。此外,激光多普勒成像系统通过提供实时血流和氧饱和度信息,提高了氧饱和度、血液供应和伤口愈合。